Back to 
STATE STREET CORP
STATE STREET CORP
ABUSShowing 8 of 28 quarters
Position history for STATE STREET CORP's holdings in ARBUTUS BIOPHARMA CORP
Yes. State Street holds 7,869,179 shares of ABUS (Arbutus Biopharma), worth $37.8M, as of its Q2 2026 13F filing. It increased the position by 1,526,669 shares (+24.1%) from Q1 2026. State Street has held ABUS since Q3 2020, across 24 quarterly 13F filings.
Current Value
$37.8M
Current Shares
7.9M
Total Value Change
+$20.8M
Total Shares Change
+3.5M
Quarter-by-Quarter History
Other major holders of ABUS: MORGAN STANLEY